REQUEST A DEMO
Total
USD $0.00
Search more companies

Alinex - Kacovska, S.R.O. (Czech Republic)

Main Activities: Pharmacies and Drug Stores
Full name: Alinex - Kacovska, S.R.O. Profile Updated: November 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Alinex - Kacovska, S.R.O. is based in Czech Republic, with the head office in Prague. The enterprise currently operates in the Pharmacies and Drug Stores sector. The company was established on January 29, 1991. The total number of employees is currently 10 - 19 (2023). From the latest financial highlights, Alinex - Kacovska, S.R.O. reported a net sales revenue increase of 14.05% in 2023. Its’ total assets recorded a growth of 5.93%. The net profit margin of Alinex - Kacovska, S.R.O. increased by 2.3% in 2023.

Headquarters
Rohacova 1480/76
Prague; The City of Prague; Postal Code: 13000

Contact Details: Purchase the Alinex - Kacovska, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Alinex - Kacovska, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Alinex - Kacovska, S.R.O. report to view the information.
Registered Capital:
Purchase the Alinex - Kacovska, S.R.O. report to view the information.
Incorporation Date:
January 29, 1991
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Alinex - Kacovska, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
14.05%
Total operating revenue
14.03%
Operating profit (EBIT)
402.56%
EBITDA
108.77%
Net Profit (Loss) for the Period
431.66%
Total assets
5.93%
Total equity
0.82%
Operating Profit Margin (ROS)
3.09%
Net Profit Margin
2.3%
Return on Equity (ROE)
4.46%
Quick Ratio
0.05%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?